Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,944 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Interim Analysis of the Phase II Study: Noninferiority Study of Doxorubicin with Upfront Dexrazoxane plus Olaratumab for Advanced or Metastatic Soft-Tissue Sarcoma.
Van Tine BA, Hirbe AC, Oppelt P, Frith AE, Rathore R, Mitchell JD, Wan F, Berry S, Landeau M, Heberton GA, Gorcsan J 3rd, Huntjens PR, Soyama Y, Vader JM, Alvarez-Cardona JA, Zhang KW, Lenihan DJ, Krone RJ. Van Tine BA, et al. Among authors: berry s. Clin Cancer Res. 2021 Jul 15;27(14):3854-3860. doi: 10.1158/1078-0432.CCR-20-4621. Epub 2021 Mar 25. Clin Cancer Res. 2021. PMID: 33766818 Free PMC article. Clinical Trial.
Phase II study of dacarbazine given with modern prophylactic anti-emetics and growth factor support to patients with metastatic, resistant soft tissue, and bone sarcoma.
Van Tine BA, Weiss MC, Hirbe AC, Oppelt PJ, Abaricia S, Trinkaus K, Luo J, Berry S, Ruff T, Callahan C, Toensikoetter J, Ley J, Siegel MJ, Dehdashti F, Siegel BA, Adkins DR. Van Tine BA, et al. Among authors: berry s. Rare Tumors. 2021 Oct 8;13:20363613211052498. doi: 10.1177/20363613211052498. eCollection 2021. Rare Tumors. 2021. PMID: 34646430 Free PMC article.
Adaptive Platform Trials in Stroke.
Lorenzi E, Crawford AM, Anderson CS, Menon B, Chen X, Mistry E, Khatri P, Elm JJ, Beall J, Saville BR, Berry SM, Lewis RJ. Lorenzi E, et al. Among authors: berry sm. Stroke. 2025 Jan;56(1):198-208. doi: 10.1161/STROKEAHA.124.045754. Epub 2024 Dec 20. Stroke. 2025. PMID: 39705391 Review.
ASO Visual Abstract: Developing a Surgical Oncology Workforce in West Africa: A Needs Assessment and Environmental Scan.
Nanji S, Alatise O, Gueye SM, Merchant S, Yawe KT, Jalink M, Ogundiran TO, Olawale B, Kolomitro K, Ka S, Berry S, Clegg-Lamptey JN, Hammad N, Dedey F, Cofie N, Osime C, Kyei I, Haji F, Ezeome E. Nanji S, et al. Among authors: berry s. Ann Surg Oncol. 2024 Dec 15. doi: 10.1245/s10434-024-16657-z. Online ahead of print. Ann Surg Oncol. 2024. PMID: 39676113 No abstract available.
CRL3ARMC5 ubiquitin ligase and Integrator phosphatase form parallel mechanisms to control early stages of RNA Pol II transcription.
Cacioppo R, Gillis A, Shlamovitz I, Zeller A, Castiblanco D, Crisp A, Haworth B, Arabiotorre A, Abyaneh P, Bao Y, Sale JE, Berry S, Tufegdžić Vidaković A. Cacioppo R, et al. Among authors: berry s. Mol Cell. 2024 Dec 19;84(24):4808-4823.e13. doi: 10.1016/j.molcel.2024.11.024. Epub 2024 Dec 11. Mol Cell. 2024. PMID: 39667934 Free article.
Creation of the Indigenous Support Line for health system navigation and culturally safe access to care: a quality improvement project.
Sheldon C, Eagle Speaker C, Ruben A, McRee N, Oster RT, Jackson A, Meckelborg L, Berry S, Robillard M, Osiowy K, Williams K, Wisdom Council Members AHS. Sheldon C, et al. Among authors: berry s. BMJ Open Qual. 2024 Dec 5;13(4):e003047. doi: 10.1136/bmjoq-2024-003047. BMJ Open Qual. 2024. PMID: 39645239 Free PMC article.
Arrayed CRISPR libraries for the genome-wide activation, deletion and silencing of human protein-coding genes.
Yin JA, Frick L, Scheidmann MC, Liu T, Trevisan C, Dhingra A, Spinelli A, Wu Y, Yao L, Vena DL, Knapp B, Guo J, De Cecco E, Ging K, Armani A, Oakeley EJ, Nigsch F, Jenzer J, Haegele J, Pikusa M, Täger J, Rodriguez-Nieto S, Bouris V, Ribeiro R, Baroni F, Bedi MS, Berry S, Losa M, Hornemann S, Kampmann M, Pelkmans L, Hoepfner D, Heutink P, Aguzzi A. Yin JA, et al. Among authors: berry s. Nat Biomed Eng. 2024 Dec 4. doi: 10.1038/s41551-024-01278-4. Online ahead of print. Nat Biomed Eng. 2024. PMID: 39633028
Plasma arginine as a predictive biomarker for outcomes with immune checkpoint inhibition in metastatic colorectal cancer: a correlative analysis of the CCTG CO.26 trial.
Ma LX, Titmuss E, Loree JM, Jonker DJ, Kennecke HF, Berry S, Couture F, Ahmad CE, Goffin JR, Kavan P, Harb M, Colwell B, Samimi S, Samson B, Abbas T, Aucoin N, Aubin F, Koski S, Tu D, O'Callaghan C, Chen EX. Ma LX, et al. Among authors: berry s. J Immunother Cancer. 2024 Dec 4;12(12):e010094. doi: 10.1136/jitc-2024-010094. J Immunother Cancer. 2024. PMID: 39631846 Free PMC article. Clinical Trial.
Phenylalanine hydroxylase deficiency diagnosis and management: A 2023 evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG).
Smith WE, Berry SA, Bloom K, Brown C, Burton BK, Demarest OM, Jenkins GP, Malinowski J, McBride KL, Mroczkowski HJ, Scharfe C, Vockley J; ACMG Board of Directors. Electronic address: documents@acmg.net. Smith WE, et al. Among authors: berry sa. Genet Med. 2024 Dec 2:101289. doi: 10.1016/j.gim.2024.101289. Online ahead of print. Genet Med. 2024. PMID: 39630157
1,944 results